A practical and scalable synthesis of the beta 3-adrenergic receptor agonist Vibegron has been developed using a streamlined chiral-pool approach from readily available 4-nitro-D-phenylalanine and (R)-mandelic acid. The synthesis features a key acid-catalyzed N-acyl iminium ion cyclization followed by a highly diastereoselective reduction, enabling efficient construction of the cis-2,5-disubstituted pyrrolidine core. Final amidation with a commercially available pyrrolopyrimidine sodium salt furnished Vibegron in excellent overall yield.